Trademark: 97059971
Word
LANIER BIOTHERAPEUTICS
Status Date
Monday, December 18, 2023
Filing Date
Tuesday, October 5, 2021
Published for Opposition
Tuesday, October 25, 2022
5 Pharmaceuticals for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; therapeutic preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; biological preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; ophthalmic preparations
42 Scientific, medical and pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; research and development of biologics; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials and testing services; information, advisory and consultancy services in relation to all of the foregoing
The mark consists of two curved members converging above and to left of the letter "L" in the word "Lanier", which is in initial caps above the word "BIOTHERAPEUTICS" in all caps.
"BIOTHERAPEUTICS"
Dec 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2023
Sou Extension 2 Granted
Dec 18, 2023
Sou Extension 2 Filed
Dec 18, 2023
Sou Teas Extension Received
Jun 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2023
Sou Extension 1 Granted
Jun 16, 2023
Sou Extension 1 Filed
Jun 16, 2023
Sou Teas Extension Received
Dec 20, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 21, 2022
Approved For Pub - Principal Register
Sep 20, 2022
Teas/Email Correspondence Entered
Sep 20, 2022
Correspondence Received In Law Office
Sep 20, 2022
Teas Response To Office Action Received
Jul 20, 2022
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jul 20, 2022
Examiner's Amendment/Priority Action E-Mailed
Jul 20, 2022
Combined Examiner's Amendment/Priority Action Automatic Entry
Jul 20, 2022
Examiners Amendment And/Or Priority Action - Completed
Jul 8, 2022
Assigned To Examiner
Oct 30, 2021
Notice Of Design Search Code E-Mailed
Oct 29, 2021
New Application Office Supplied Data Entered
Oct 8, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
